Abstract:Zhi Yang, 1 Yao Song, 1 Bangtao Chen, 2 Fei Hao 1 1 Department of Dermatology, Third Affiliated Hospital of Chongqing Medical University, Chongqing, 401120, People's Republic of China; 2 Department of Dermatology, Chongqing University Three Gorges Hospital, School of Medicine, Chongqing University, Chongqing, 404100, People's Republic of China Correspondence: Bangtao Chen; Fei Hao, Email ; Objective: To analyze the associations of the gut and circulating microbiota with circulating vitamin D 3 (VD3), type I interferon (IFNI), systemic inflammation, and clinical profiles in chronic spontaneous urticaria (CSU) patients. Methods: A total of 36 CSU patients with VD3 insufficiency (VDI; serum 25(OH)VD3 < 30 ng/mL) and 36 sex-, age-, and body mass index–matched CSU patients with non-VDI were enrolled. Fecal and serum bacteria were identified through 16S rRNA sequencing, and serum 25(OH)VD3 and inflammation biomarkers were assessed using ELISA kits. IFNI response was determined by measuring the stimulatory activity of serum on IFNI-stimulated response element in HEK293 cells in vitro with luciferase assays. Results: Higher urticarial activity score over 7 days (UAS7), higher frequency of levocetirizine resistance, and more severe proinflammation but weaker IFNI response were observed in VDI than non-VDI patients (all P < 0.05). IFNI response was strongly positively associated with serum 25(OH)VD3 level in both groups ( P < 0.001). Compared to non-VDI patients, abundance of the fecal genera Prevotella 9, Escherichia–Shigella , and Klebsiella was significantly increased, while Bacteroides , Faecalibacterium , and Agathobacter were remarkably reduced in VDI patients (all P < 0.05). Burkholderia – Caballeronia–Paraburkholderia (40.95%), Acinetobacter (3.05%), and Aquabacterium (2.37%) were the top three bacteria in sera from VDI patients. Both serum 25(OH)VD3 level and IFNI response were positively associated with fecal Bacteroides in the two groups ( P < 0.05). In non-VDI patients, there were moderately positive associations between IFNI response and fecal Lachnoclostridium , unclassified_f__Lachnospiraceae, and Phascolarctobacterium and between serum 25(OH)VD3 level and fecal Lachnoclostridium (all P < 0.01). Circulating microbiota in VDI patients was closely related only to proinflammation and UAS7 (both P < 0.05). Conclusion: Changes in gut but not circulating microbiota composition are associated with serum 25(OH)VD3 insufficiency and impaired IFNI homeostasis, which points to greater disease severity (UAS7) and systemic proinflammation in CSU patients. Keywords: chronic spontaneous urticaria, microbiota, vitamin D 3 , type I interferon, inflammation Chronic spontaneous urticaria (CSU), a clinical subtype that accounts for about two thirds of cases of chronic urticaria, is generally regarded as a debilitating skin disorder characterized by recurrent episodes of intensely pruritic wheals with or without associated angioedema persisting ≥6 weeks. Although affecting up to 0.67% of the global population at some point during life, it is obviously self-limiting. 1 However, CSU patients still come to dermatology departments seeking help for the intolerable itching that significantly impairs sleep and daily activities. Regrettably, up to 40%–60% of patients receiving first-line treatment (second-generation nonsedating H 1 antihistamines [nsAHs] at licensed doses) still require higher doses of nsAHs or other approaches, including glucocorticoids, cyclosporine, or biologics, which inevitably brings substantial financial burden and drug-safety concerns for them. 2 The release of histamine and other inflammatory mediators upon mast-cell activation is widely recognized as central to CSU pathophysiology. We and others have shown that CSU is also involved other systemic abnormalities, including autoimmunity, imbalance of T h 1/T h 2/T h 17 cytokines, enteric dysbacteriosis, abnormal activation of the coagulation system, and vitamin D 3 (VD3) insufficiency (VDI). 3,4 Noteworthily, the above abnormalities may not concurrently present in one CSU patient, though one of them may predominate. Data concerning serum 25(OH)VD3 concentration and partial clinical benefit in CSU with VD3 supplementation indicate a need for dermatologists to focus on the possible causation and regulating effects of VD3 in the heterogeneity of CSU pathogenesis. 5 To better manage this frustrating disease with VD3, efforts to -Abstract Truncated-

Lower serum B12 vitamin concentrations are not accompanied by hyperhomocysteinaemia in chronic spontaneous urticaria

Participation of the coagulation system and fibrinolysis as well as selected biomarkers in pathogenesis of chronic urticaria with various activity degree

Serum Levels of 25-hydroxyvitamin D in Chronic Urticaria and its Association with Disease Activity: A Case Control Study

25-hydroxyvitamin D levels are low but not associated with disease activity in chronic spontaneous urticaria and depression

Serum food-specific IgG and specific IgG4 in 655 patients with chronic urticaria

The Correlation between Serum Vitamin D and Total IgE Levels and Chronic Spontaneous Urticaria among Chinese Population: A Retrospective Study

Intersecting pathways: evaluating inflammatory markers and metabolism in chronic spontaneous urticaria with a multi‐marker approach

Associations of Gut and Circulating Microbiota with Circulating Vitamin D3, Type I Interferon, and Systemic Inflammation in Chronic Spontaneous Urticaria Patients

Relationship between vitamin D and chronic spontaneous urticaria: a systematic review

Low B12 levels in chronic idiopathic urticaria

Clinical Significance of Plasma Homocysteine in the Coronary Atherosclerosis Patients

Gut Microbiome and Serum Metabolome Analyses Identify Unsaturated Fatty Acids and Butanoate Metabolism Induced by Gut Microbiota in Patients With Chronic Spontaneous Urticaria

Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria

Increased Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Chronic and Severe Urticaria

Efficacy and safety of active vitamin D supplementation in chronic spontaneous urticaria patients

A study on serum zonulin in chronic spontaneous urticaria patients

Chronic spontaneous urticaria: Evidence of systemic microcirculatory changes

Circulating level of the platelet-derived CXC chemokine platelet factor 4 in chronic urticaria patients with or without coexistent euthyroid Hashimoto's thyroiditis

Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria

Non-Skin-Related Symptoms are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results from CURE

Abnormalities in Gut Microbiota and Metabolism in Patients With Chronic Spontaneous Urticaria